BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27114096)

  • 1. Peptide backbone modification in the bend region of amyloid-β inhibits fibrillogenesis but not oligomer formation.
    Johnson EC; Lanning JD; Meredith SC
    J Pept Sci; 2016 May; 22(5):368-73. PubMed ID: 27114096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Mechanism of Amyloid Fibril Formation.
    Galzitskaya O
    Curr Protein Pept Sci; 2019; 20(6):630-640. PubMed ID: 30686252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique molecular signatures of Alzheimer's disease amyloid β peptide mutations and deletion during aggregate/oligomer/fibril formation.
    Poduslo JF; Howell KG
    J Neurosci Res; 2015 Mar; 93(3):410-23. PubMed ID: 25377128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure.
    Valle-Delgado JJ; Alfonso-Prieto M; de Groot NS; Ventura S; Samitier J; Rovira C; Fernàndez-Busquets X
    FASEB J; 2010 Nov; 24(11):4250-61. PubMed ID: 20585030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AlphaB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid beta-peptide and beta2-microglobulin.
    Raman B; Ban T; Sakai M; Pasta SY; Ramakrishna T; Naiki H; Goto Y; Rao ChM
    Biochem J; 2005 Dec; 392(Pt 3):573-81. PubMed ID: 16053447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-like fibril formation by tachykinin neuropeptides and its relevance to amyloid β-protein aggregation and toxicity.
    Singh PK; Maji SK
    Cell Biochem Biophys; 2012 Sep; 64(1):29-44. PubMed ID: 22628076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.
    Baumketner A; Krone MG; Shea JE
    Proc Natl Acad Sci U S A; 2008 Apr; 105(16):6027-32. PubMed ID: 18408165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting the behaviour of β-amyloid peptide variants during oligomerization and fibrillation.
    Shi JM; Zhang L; Liu EQ
    J Pept Sci; 2017 Nov; 23(11):810-817. PubMed ID: 28795459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.
    Benseny-Cases N; Klementieva O; Cladera J
    Subcell Biochem; 2012; 65():53-74. PubMed ID: 23224999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
    Gu L; Tran J; Jiang L; Guo Z
    J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational backbone mutagenesis of Abeta peptides: probing the role of backbone hydrogen bonds in aggregation.
    Takeda T; Klimov DK
    J Phys Chem B; 2010 Apr; 114(14):4755-62. PubMed ID: 20302321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationally designed turn promoting mutation in the amyloid-β peptide sequence stabilizes oligomers in solution.
    Rajadas J; Liu CW; Novick P; Kelley NW; Inayathullah M; Lemieux MC; Pande VS
    PLoS One; 2011; 6(7):e21776. PubMed ID: 21799748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the aggregation mechanism of Aβ(25-40).
    Xiong J; JiJi RD
    Biophys Chem; 2017 Jan; 220():42-48. PubMed ID: 27856006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between gold nanoparticles and amyloid β25-35 peptide.
    Peng J; Weng J; Ren L; Sun LP
    IET Nanobiotechnol; 2014 Dec; 8(4):295-303. PubMed ID: 25429511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To Be Fibrils or To Be Nanofilms? Oligomers Are Building Blocks for Fibril and Nanofilm Formation of Fragments of Aβ Peptide.
    Selivanova OM; Surin AK; Ryzhykau YL; Glyakina AV; Suvorina MY; Kuklin AI; Rogachevsky VV; Galzitskaya OV
    Langmuir; 2018 Feb; 34(6):2332-2343. PubMed ID: 29338255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural differences between amyloid beta oligomers.
    Breydo L; Kurouski D; Rasool S; Milton S; Wu JW; Uversky VN; Lednev IK; Glabe CG
    Biochem Biophys Res Commun; 2016 Sep; 477(4):700-705. PubMed ID: 27363332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
    Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
    J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange.
    Kheterpal I; Zhou S; Cook KD; Wetzel R
    Proc Natl Acad Sci U S A; 2000 Dec; 97(25):13597-601. PubMed ID: 11087832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide backbone modifications of amyloid β (1-40) impact fibrillation behavior and neuronal toxicity.
    Schwarze B; Korn A; Höfling C; Zeitschel U; Krueger M; Roßner S; Huster D
    Sci Rep; 2021 Dec; 11(1):23767. PubMed ID: 34887476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.